WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

G GENITO URINARY SYSTEM AND SEX HORMONES
G02 OTHER GYNECOLOGICALS

Analgesics used in dysmenorrhea, see N02B - Other analgesics and antipyretics and M01A - Antiinflammatory and antirheumatic products, non-steroids.


G02C OTHER GYNECOLOGICALS

G02CA Sympathomimetics, labour repressants

This group includes sympathomimetics used to repress labour. Similar adrenergic drugs, which are mainly used in the treatment of asthma, are classified in R03C.

Fenoterol infusion only intended for repressing preterm labour is classified in this group, while other systemic formulations of fenoterol are classified in R03CC04.

The DDDs are based on use as labour repressants.

G02CB Prolactine inhibitors

Cabergoline and bromocriptine low dose tablets are classified in this group. Cabergoline and bromocriptine tablets in higher strengths are classified in N04 - Anti-Parkinson drugs.

Lisuride tablets in high strength (0.2 mg) are classified in this group, while low strength tablets (25 mcg) are classified in N02C -Antimigraine preparations.

The DDDs are based on use as lactation inhibitors. The DDD for parenteral depot formulations of bromocriptine is equal to the DDD for oral administration, based on the assumption that the single dose parenteral treatment equals 14 days of oral treatment.

G02CC Antiinflammatory products for vaginal administration

This group comprises e.g. non-steroidal antiinflammatory drugs for vaginal administration.

G02CX Other gynecologicals

Last updated: 2018-12-13